Hsbc Holdings PLC Has $73.92 Million Position in GE HealthCare Technologies Inc. $GEHC

Hsbc Holdings PLC cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 898,798 shares of the company’s stock after selling 18,137 shares during the period. Hsbc Holdings PLC’s holdings in GE HealthCare Technologies were worth $73,920,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of GEHC. Empowered Funds LLC increased its stake in GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after purchasing an additional 1,665 shares in the last quarter. Acadian Asset Management LLC acquired a new stake in GE HealthCare Technologies in the first quarter worth $259,000. Cresset Asset Management LLC boosted its position in shares of GE HealthCare Technologies by 12.5% during the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after purchasing an additional 865 shares in the last quarter. Jump Financial LLC boosted its position in shares of GE HealthCare Technologies by 317.6% during the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after purchasing an additional 21,396 shares in the last quarter. Finally, Gamco Investors INC. ET AL grew its holdings in shares of GE HealthCare Technologies by 8.6% in the 2nd quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after buying an additional 320 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $65.57 on Friday. The firm has a market cap of $29.83 billion, a price-to-earnings ratio of 15.69, a PEG ratio of 1.78 and a beta of 0.72. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The company’s fifty day simple moving average is $63.70 and its 200 day simple moving average is $73.29. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s payout ratio is 3.35%.

Insider Activity at GE HealthCare Technologies

In other news, Director Rodney F. Hochman bought 1,618 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average price of $62.03 per share, with a total value of $100,364.54. Following the transaction, the director owned 1,618 shares in the company, valued at $100,364.54. This represents a ? increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Peter J. Arduini bought 4,169 shares of the business’s stock in a transaction on Thursday, April 30th. The stock was purchased at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the purchase, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. This represents a 1.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 21,847 shares of company stock valued at $1,361,355 over the last ninety days. Company insiders own 0.36% of the company’s stock.

Analyst Ratings Changes

GEHC has been the subject of a number of recent analyst reports. The Goldman Sachs Group restated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Oppenheimer reissued an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Jefferies Financial Group dropped their price target on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Finally, Mizuho cut their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $80.20.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.